However, as with any medical procedure, there may be some minor side effects at the injection site , such as swelling or bruising
It is currently known that one of the main causes of facial aging is the changes in the facial fat compartments [1,2]
In peptide research, BPC-157 is frequently studied for its cytoprotective properties and its potential role in supporting tissue repair, recovery responses, and structural healing processes
triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial
Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement
Revised: May 2025 NDC 0024-5761-05 Rx only SOLIQUA 100/33 (insulin glargine and lixisenatide) injection For Single Patient Use Only 100 units/mL and 33 mcg/mL With each unit of insulin glargine, the pen also delivers 0.33 mcg of lixisenatide Only for Doses from 15 to 60 Units For subcutaneous injection only Dispense with the medication guide Solution for injection in a SoloStar disposable insulin delivery device Never remove medication using a syringe Do not mix with other insulins Use only if solution is clear and colorless with no particles visible Five 3 mL prefilled pens (15 mL total) Dispense in this sealed carton *Needles not included (see back panel) sanofi
